Related references
Note: Only part of the references are listed.Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway
Qiuhuan Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating beta-catenin
Ruiduo Cheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma
Maryam Delforoush et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers
Jianyu Cai et al.
ONCOTARGET (2017)
Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma
Baozhu Zhang et al.
THORACIC CANCER (2017)
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
Xin Chen et al.
CANCER AND METASTASIS REVIEWS (2017)
The role of deubiquitinases in breast cancer
Zhenna Xiao et al.
CANCER AND METASTASIS REVIEWS (2016)
Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis
Ling Nan et al.
SCIENTIFIC REPORTS (2016)
Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenstroom macroglobulinaemia tumour cells
Kasyapa Chitta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review
Rosalba Camicia et al.
MOLECULAR CANCER (2015)
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
Ze Tian et al.
BLOOD (2014)
Diffuse large B-cell lymphoma-treatment approaches in the molecular era
Mark Roschewski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
High expression of UCH37 is significantly associated with poor prognosis in human epithelial ovarian cancer
Lin Wang et al.
TUMOR BIOLOGY (2014)
IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL
Hendrik Nogai et al.
BLOOD (2013)
Diffuse large B-cell lymphoma
Maurizio Martelli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Deubiquitination of Dishevelled by Usp14 is required for Wnt signaling
H. Jung et al.
ONCOGENESIS (2013)
Expression and Clinical Significance of UCH37 in Human Esophageal Squamous Cell Carcinoma
Yanjie Chen et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
Proteasome deubiquitinases as novel targets for cancer therapy
Padraig D'Arcy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Inhibition of proteasome deubiquitinating activity as a new cancer therapy
Padraig D'Arcy et al.
NATURE MEDICINE (2011)
Molecular pathogenesis of diffuse large B-cell lymphoma
Christof Schneider et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2011)
Mechanisms of Disease: Aggressive Lymphomas.
Georg Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Role of Mitochondria in Apoptosis
Chunxin Wang et al.
ANNUAL REVIEW OF GENETICS (2009)
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma
Kieron Dunleavy et al.
BLOOD (2009)
Triptolide Inhibits Bcr-Abl Transcription and Induces Apoptosis in STI571-resistant Chronic Myelogenous Leukemia Cells Harboring T315I Mutation
Xianping Shi et al.
CLINICAL CANCER RESEARCH (2009)
Deubiquitination of CXCR4 by USP14 Is Critical for Both CXCL12-induced CXCR4 Degradation and Chemotaxis but Not ERK Activation
Marjelo A. Mines et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
Georg Lenz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The proteasome inhibitor bortezomib acts independently of p53 and induces cell death via apoptosis and mitotic catastrophe in B-cell lymphoma cell lines
Sandra J. Strauss et al.
CANCER RESEARCH (2007)
Control of the autophagy maturation step by the MAPK ERK and p38 - Lessons from environmental carcinogens
Elisabeth Corcelle et al.
AUTOPHAGY (2007)
Reversible ubiquitination regulates the Smad/TGF-β signalling pathway
S. J. Wicks et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling
SJ Wicks et al.
ONCOGENE (2005)
A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
D Chauhan et al.
CANCER CELL (2005)
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma
J Iqbal et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Rituximab in the treatment of diffuse large B-Cell lymphomas
B Coiffier
SEMINARS IN ONCOLOGY (2002)
Share Paper
